Split History
ETFs Holding LCI »    LCI Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions. According to our LCI split history records, Lannett has had 1 split.
LCI split history picture
Lannett (LCI) has 1 split in our LCI split history database. The split for LCI took place on March 03, 2003. This was a 3 for 2 split, meaning for each 2 shares of LCI owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split.

When a company such as Lannett splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the LCI split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lannett shares, starting with a $10,000 purchase of LCI, presented on a split-history-adjusted basis factoring in the complete LCI split history. LCI split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/29/2013
End date: 01/25/2023
Start price/share: $5.96
End price/share: $0.62
Dividends collected/share: $0.00
Total return: -89.60%
Average Annual Total Return: -20.26%
Starting investment: $10,000.00
Ending investment: $1,040.64
Years: 9.99
Date Ratio
03/03/20033 for 2
LCI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LGND Split History
LH Split History
LIFE Split History
LJPC Split History
LLY Split History
LPTN Split History
LUX Split History
LXRX Split History
MACK Split History
MBOT Split History

Also explore: LCI shares outstanding history

Email EnvelopeFree LCI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
OpGen, Inc. (OPGN)
Tenax Therapeutics, Inc. (TENX)
Biora Therapeutics, Inc. (BIOR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LCI Insider Buying

LCI Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.